Mukand Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 7, 2025, 2:34 pm

Quick Insight

Mukand Ltd, operating in the specialized steel alloys sector, presents an intriguing investment case with its current share price at ₹139 and a market capitalization of ₹2,014 crore. The company's P/E ratio of 27.7 suggests a premium valuation relative to its net profit of ₹76 crore, while a return on equity (ROE) of 7.84% and return on capital employed (ROCE) of 9.91% indicate moderate profitability. Notably, with promoter ownership at 74.70%, investor confidence appears robust, though foreign institutional investors (FIIs) hold a mere 0.20%. The company’s significant borrowings of ₹1,559 crore against reserves of ₹805 crore, coupled with an interest coverage ratio (ICR) of 2.34x, raises concerns about financial leverage. Mukand’s cash conversion cycle (CCC) of 163 days also suggests potential inefficiencies in operational management. Overall, while Mukand Ltd has a solid

Competitors of Mukand Ltd

All Competitor Stocks of Mukand Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:23 am

Below is a detailed analysis of the quarterly data for Mukand Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 1,107.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,262.00 Cr. (Dec 2024) to 1,107.00 Cr., marking a decrease of 155.00 Cr..
• For Expenses, as of Mar 2025, the value is 1,042.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,190.00 Cr. (Dec 2024) to 1,042.00 Cr., marking a decrease of 148.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 65.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Dec 2024) to 65.00 Cr., marking a decrease of 7.00 Cr..
• For OPM %, as of Mar 2025, the value is 6.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 6.00%.
• For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Dec 2024) to 6.00 Cr., marking an increase of 4.00 Cr..
• For Interest, as of Mar 2025, the value is 33.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 32.00 Cr. (Dec 2024) to 33.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 13.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Dec 2024) to 24.00 Cr., marking a decrease of 5.00 Cr..
• For Tax %, as of Mar 2025, the value is 55.00%. The value appears to be increasing, which may not be favorable. It has increased from 49.00% (Dec 2024) to 55.00%, marking an increase of 6.00%.
• For Net Profit, as of Mar 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Dec 2024) to 11.00 Cr., marking a decrease of 4.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.75. The value appears to be declining and may need further review. It has decreased from 1.03 (Dec 2024) to 0.75, marking a decrease of 0.28.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:21 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:44 pm

Below is a detailed analysis of the balance sheet data for Mukand Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 145.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 145.00 Cr..
• For Reserves, as of Mar 2025, the value is 805.00 Cr.. The value appears strong and on an upward trend. It has increased from 760.00 Cr. (Mar 2024) to 805.00 Cr., marking an increase of 45.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,559.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,489.00 Cr. (Mar 2024) to 1,559.00 Cr., marking an increase of 70.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,033.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 636.00 Cr. (Mar 2024) to 1,033.00 Cr., marking an increase of 397.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,542.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,030.00 Cr. (Mar 2024) to 3,542.00 Cr., marking an increase of 512.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 539.00 Cr.. The value appears strong and on an upward trend. It has increased from 452.00 Cr. (Mar 2024) to 539.00 Cr., marking an increase of 87.00 Cr..
• For CWIP, as of Mar 2025, the value is 140.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2024) to 140.00 Cr., marking an increase of 106.00 Cr..
• For Investments, as of Mar 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 29.00 Cr., marking an increase of 19.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,833.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,534.00 Cr. (Mar 2024) to 2,833.00 Cr., marking an increase of 299.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,542.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,030.00 Cr. (Mar 2024) to 3,542.00 Cr., marking an increase of 512.00 Cr..

However, the Borrowings (1,559.00 Cr.) are higher than the Reserves (805.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Mukand Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 7.11. This value is within the healthy range. It has decreased from 11.89 (Mar 23) to 7.11, marking a decrease of 4.78.
• For Diluted EPS (Rs.), as of Mar 24, the value is 7.11. This value is within the healthy range. It has decreased from 11.89 (Mar 23) to 7.11, marking a decrease of 4.78.
• For Cash EPS (Rs.), as of Mar 24, the value is 10.55. This value is within the healthy range. It has decreased from 15.96 (Mar 23) to 10.55, marking a decrease of 5.41.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 63.74. It has increased from 59.08 (Mar 23) to 63.74, marking an increase of 4.66.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 63.74. It has increased from 59.08 (Mar 23) to 63.74, marking an increase of 4.66.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 358.09. It has decreased from 385.27 (Mar 23) to 358.09, marking a decrease of 27.18.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 21.31. This value is within the healthy range. It has decreased from 28.24 (Mar 23) to 21.31, marking a decrease of 6.93.
• For PBIT / Share (Rs.), as of Mar 24, the value is 17.87. This value is within the healthy range. It has decreased from 24.62 (Mar 23) to 17.87, marking a decrease of 6.75.
• For PBT / Share (Rs.), as of Mar 24, the value is 8.78. This value is within the healthy range. It has decreased from 12.37 (Mar 23) to 8.78, marking a decrease of 3.59.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 7.11. This value is within the healthy range. It has decreased from 12.34 (Mar 23) to 7.11, marking a decrease of 5.23.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 7.11. This value is within the healthy range. It has decreased from 11.89 (Mar 23) to 7.11, marking a decrease of 4.78.
• For PBDIT Margin (%), as of Mar 24, the value is 5.95. This value is below the healthy minimum of 10. It has decreased from 7.33 (Mar 23) to 5.95, marking a decrease of 1.38.
• For PBIT Margin (%), as of Mar 24, the value is 4.99. This value is below the healthy minimum of 10. It has decreased from 6.38 (Mar 23) to 4.99, marking a decrease of 1.39.
• For PBT Margin (%), as of Mar 24, the value is 2.45. This value is below the healthy minimum of 10. It has decreased from 3.21 (Mar 23) to 2.45, marking a decrease of 0.76.
• For Net Profit Margin (%), as of Mar 24, the value is 1.98. This value is below the healthy minimum of 5. It has decreased from 3.20 (Mar 23) to 1.98, marking a decrease of 1.22.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.98. This value is below the healthy minimum of 8. It has decreased from 3.08 (Mar 23) to 1.98, marking a decrease of 1.10.
• For Return on Networth / Equity (%), as of Mar 24, the value is 11.14. This value is below the healthy minimum of 15. It has decreased from 20.11 (Mar 23) to 11.14, marking a decrease of 8.97.
• For Return on Capital Employeed (%), as of Mar 24, the value is 10.73. This value is within the healthy range. It has decreased from 15.03 (Mar 23) to 10.73, marking a decrease of 4.30.
• For Return On Assets (%), as of Mar 24, the value is 3.37. This value is below the healthy minimum of 5. It has decreased from 5.40 (Mar 23) to 3.37, marking a decrease of 2.03.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 1.56. This value exceeds the healthy maximum of 1. It has decreased from 1.69 (Mar 23) to 1.56, marking a decrease of 0.13.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.62. This value exceeds the healthy maximum of 1. It has decreased from 1.76 (Mar 23) to 1.62, marking a decrease of 0.14.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.66. It has decreased from 1.69 (Mar 23) to 1.66, marking a decrease of 0.03.
• For Current Ratio (X), as of Mar 24, the value is 3.72. This value exceeds the healthy maximum of 3. It has increased from 3.06 (Mar 23) to 3.72, marking an increase of 0.66.
• For Quick Ratio (X), as of Mar 24, the value is 1.24. This value is within the healthy range. It has increased from 1.16 (Mar 23) to 1.24, marking an increase of 0.08.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.16. This value is below the healthy minimum of 4. It has decreased from 2.77 (Mar 23) to 2.16, marking a decrease of 0.61.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 28.14. This value is within the healthy range. It has increased from 12.61 (Mar 23) to 28.14, marking an increase of 15.53.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 18.96. This value is below the healthy minimum of 20. It has increased from 9.66 (Mar 23) to 18.96, marking an increase of 9.30.
• For Earning Retention Ratio (%), as of Mar 24, the value is 71.86. This value exceeds the healthy maximum of 70. It has decreased from 87.39 (Mar 23) to 71.86, marking a decrease of 15.53.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 81.04. This value exceeds the healthy maximum of 70. It has decreased from 90.34 (Mar 23) to 81.04, marking a decrease of 9.30.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 2.34. This value is below the healthy minimum of 3. It has increased from 2.31 (Mar 23) to 2.34, marking an increase of 0.03.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.78. This value is below the healthy minimum of 3. It has decreased from 2.01 (Mar 23) to 1.78, marking a decrease of 0.23.
• For Enterprise Value (Cr.), as of Mar 24, the value is 3,583.98. It has increased from 3,488.14 (Mar 23) to 3,583.98, marking an increase of 95.84.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.69. This value is below the healthy minimum of 1. It has increased from 0.62 (Mar 23) to 0.69, marking an increase of 0.07.
• For EV / EBITDA (X), as of Mar 24, the value is 11.64. This value is within the healthy range. It has increased from 8.55 (Mar 23) to 11.64, marking an increase of 3.09.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.41. This value is below the healthy minimum of 1. It has increased from 0.36 (Mar 23) to 0.41, marking an increase of 0.05.
• For Retention Ratios (%), as of Mar 24, the value is 71.85. This value exceeds the healthy maximum of 70. It has decreased from 87.38 (Mar 23) to 71.85, marking a decrease of 15.53.
• For Price / BV (X), as of Mar 24, the value is 2.33. This value is within the healthy range. It has decreased from 2.37 (Mar 23) to 2.33, marking a decrease of 0.04.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.41. This value is below the healthy minimum of 1. It has increased from 0.36 (Mar 23) to 0.41, marking an increase of 0.05.
• For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 23) to 0.04, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness